History
Company history
1947
Rodolfo Ferrari and Carlo Callerio founded the Italian company SPA to produce Penicillin
1950
Collaboration between SPA and Sir Alexander Fleming to develop a large scale Penicillin and Lysozyme production company
1972
SPA established first lysozyme plant on industrial scale at NIVE Nunspeet The Netherlands
1983
SPA estabilished Fordras SA specialized in Lysozyme sales API in Japan and worldwide
1994
Canadian former Inovatech, Neova Technologies Inc. started Lysozyme and Trypsin production in the US Fordras plant . SPA develops a new systemic antifungal SPK 843
2002
Spin off of Lysozyme and SPK 843 from SPA
2008
Merger of Fordras, Neova Technologies and KD Pharma under Bioseutica BV
2011
New Shareholders structure – Group reorganisation to deal with market opportunities
2012
Bioseutica expands on new specialties like: NA2R, Ovotransferrin and Entegard
2017
Bioseutica acquires Belovo from BNL Food Group in Belgium. Development of AquaTryp